Diabetes

The clearance brings US readers a feature long available in Europe, and paves the way for data plays.

Published today in the Lancet, the investigation of 86 pediatric and adult Type 1 patients compared the partially automated system to a manual sensor-augmented pump therapy.

The new product adds night-time alarms, making the low-cost 14-day CGM more useful.

The market comprised $98 million in revenue during 2017, and is beginning to move away from stand-alone devices or apps. 

Realtime blood glucose information will allow Livongo's platform to deliver more insights, coaching to people with diabetes.

In 2016, UnitedHealthcare and Medtronic cut a deal that established the latter’s devices as the preferred insulin pumps for United members with diabetes.

Researchers from the University of Waterloo have described a proof-of-concept system that uses Google’s Soli — an experimental, radar-based gesture tracker co-developed with Infineon — to track concentrations of glucoses within a solution.

Healthy Interactions, a population health company that offers both digital and in-person programs for chronic disease management and education, announced last week that it has added two new programs, for cardiovascular disease and depression, to its portfolio.

Working with digital diabetes prevention program (DPP) provider Omada Health — and combining that intervention with lab and biometric screenings — lab company Quest Diagnostics reduced risk for diabetes in one-third of a 107-employee cohort.

This weekend saw the kickoff of the American Diabetes Association’s 78th annual conference, and with it a slew of new data from diabetes management players.